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Matrix metalloproteases (MMP) constitute a family of 
proteolytic enzymes degrading extracellular matrix 
components. Their activity is inhibited by tissue 
inhibitors of metallo prot eases (TIMP). Previous stud-
ies have demonstrated that various cytokines can 
modulate MMP and TIMP gene expression. In this 
study, we demonstrate that interferon-y coordinately 
upregulates MMP-l (interstitial collagenase) and 
MMP-3 (stromelysin-l) gene expression in cultured 
keratinocytes, as determined at the mRNA steady-
state levels, and this effect is dependent on on-going 
protein synthesis. In contrast, there was no effect on 
TIMP-l gene expression. Enhanced MMP-l expres-
sion by IFN-y was also demonstrated at the protein 
level by Western analysis. Transient transfections 
with MMP-l and MMP-3 promoter/reporter gene 
atrix metalloproteases (MMPs) constitute a fam-
ily of structurally related proteolytic enzymes, 
yet their specific activities are divergent [1,2]. 
For example, MMP-1 (interstitial collagenase) is 
the major enzyme responsible for degradation of 
extracellular fibers comprised of collagen types I, II, or III [1]. 
MMP-3 (stromelysin-l) depicts a broad spectrum of proteolytic 
activities, including degradation of various gelatins, proteoglycan 
link protein, fibronectin, and laminin, as well as native collagens 
type III, IV, V, and IX [1]. Furthermore, MMP-3 is required for 
maximal activation of MMP-1 in physiologic situations [3]. 
The activities ofMMP-1 and MMP-3 are regulated by a family of 
tissue inhibitor of metalloproteases (TIMP) [1-S]. The major 
inhibitor of MMP-1 and MMP-3 is TIMP-1, a 28.S-kDa glycopro-
tein, which forms 1: 1 stoichiometric complexes with these pro-
teases [1,6]. Thus, the relative levels of TIMP-1 regulate the 
activity of MMPs in tissue. Any imbalance between the proteolytic 
activities and their inhibitors could potentially lead to a pathologic 
condition, as exemplified by degradation of articular connective 
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constructs revealed no response to IFN-y, whereas 
incubation of keratinocytes with this cytokine ap-
peared to stabilize the MMP-l mRNA, resulting in 
reduced turnover of the transcript. These data sug-
gest that IFN-y enhances MMP gene expression at the 
post-transcriptional level. The altered MMP expres-
sion by IFN-y without concomitant effect on TIMP 
gene expression potentially leads to imbalance be-
tween these proteases and their inhibitors, and en-
hanced proteolytic activity may play a role in the 
remodeling of cutaneous tissue involving inflamma-
tory processes, such as wound healing. Key words: 
matrix metalloproteases/tissue repair/extracellular matrix 
tuvnover/injlammatovy mediators. J Invest Devmatol 104: 
384-390, 1995 
tissue in arthritic diseases or accumulation of collagen in cutaneous 
collagenomas due to deficient collagenase activity [7,8]. 
Previously, a variety of cytokines and growth factors have been 
shown to regulate the expression of MMP-1 and MMP-3, as well as 
TIMP [2,9]. This modulation is often selective, and different 
cytokines can alter the balance between the active proteases and 
their inhibitors. One of the cytokines previously shown to modulate 
the activity of MMP-1 and MMP-3 is interferon-y (IFN-y), a 
physiologic mediator synthesized and released primarily by helper 
T -lymphocytes [10]. Previous studies have demonstrated that 
IFN-y decreases the activity of MMP-1 in rheumatoid synovial 
fibroblasts, human articular chondrocytes, and human alveolar 
macrophages in culture [11-13]. Besides inhibiting constitutive 
expression of MMP-1, IFN-y also counteracts interleukin-1-in-
duced MMP-1 production [12]. Similarly, the expression of 
MMP-3 in fibroblast cultures was found to be inhibited by the 
addition of IFN-y, whereas the levels of TIMP were essentially 
unaltered [4]. IFN-y also potently suppressed lipopolysaccharide-
induced production of MMP-3 in human macrophages, whereas 
inhibition ofTIMP synthesis required fifty- to a hundredfold higher 
concentrations of this cytokine [13]. Thus, these previous studies 
suggest that IFN-y is primarily inhibitory for MMP activity in in. 
vitro culture systems utilizing a variety of different cell types. 
Human epidermal keratinocytes in culture have recently been 
shown to synthesize various MMPs, including MMP-1, MMP-2 
(72-kDa gelatinase), MMP-3, and MMP-9 (92-kDa gelatinase) 
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[14-16]. In addition, cultured keratinocytes constitutively express 
TIMP [15]. MMP-l synthesis was shown to be enhanced by 
keratinocytes cultured on type I or type IV collagen [17], whereas 
the constitutive synthesis of MMP-9 was enhanced by type I 
collagen and decreased by type IV collagen matrices [18]. Thus, the 
extracellular microenvironment, as well as soluble mediators, such 
as IFN-y, can alter the activities of tissue MMPs. 
In this study, we have examined the expression of MMP-l and 
MMP-3, as well as of TIMP, in human epidermal keratinocytes in 
culture. 
MA TERlALS AND METHODS 
Northern Analyses For RNA isolation, human adult keratinocytes were 
cultured in serum-free, low-calcium (0.15 mM) medium, supplemented 
with epidermal growth factor, hydrocortisone, insulin, and bovine pituitary 
extract (keratinocyte growth medium, Clonetics Corporation, La Jolla, 
CA). Some cultures were incubated with recombinant human IFN-)' 
(Boehringer Mannheim, Indianapolis, IN), in concentrations indicated in 
Results. Cycloheximide, 10 J.,Lg/ml, was added to some cultures to inhibit 
on-going protein synthesis. For Northern analysis, RNA was isolated from 
cultured cells by a single-step extraction procedure [19]. Total RNA, 30 J.,Lg 
per lane, was fractionated on 1% agarose gel and transferred to nitrocellu-
lose filters, and Northern hybridizations were performed with the cDNAs 
labeled radioactive with ae2p]GTP and a[32P]CTP by nick translation [20]. 
The following cDNAs were used for hybridizations: for MMP-l (interstitial 
collagenase), a 2.0-kb human cDNA [21]; for MMP-3 (stromelysin-l), a 
human 1.5-kb cDNA [22]; and for TIMP, a 0.7-kb cDNA, kindly provided 
by Dr. Carmichael, Synergen Corp., Boulder, CO. As a constitutively 
expressed control, a rat glyceraldehyde-3-phosphate dehydrogenase cDNA 
[23] was used for hybridization. The hybridization and washing conditions 
were the same as reported previously [24]. 
Western Analysis To determine the amount of inmmnoreactive colla-
genase, the cell culture media after 24 h of incubation with or without 
IFN-)' were concentrated by ultrafiltration (Centricon, Amicon, Beverly, 
MA). Samples corresponding to the same volume of the original medium 
were electrophoresed on 10% sodium dodecylsulfate-polyacrylamide gels, 
and the proteins were transferred to nitrocellulose filters by electroblotting. 
The immunoreactive collagenase in the filters was detected by incubation 
with a polyclonal rabbit anti-human collagenase antibody [25] (kindly 
provided by Dr. William Parks and Dr. Howard Welgus, Jewish Hospital, 
Washington University Medical Center, St. Louis, MO). The secondary 
antibody consisted of goat anti-rabbit IgG conjugated with alkaline phos-
phatase, and the antibody complexes were visualized by a commercial kit 
(Promega, Madison, WI). 
Transient Cell Transfections Promoter-CA T constructs for MMP-l 
and MMP-3 were used for transient transfections of cultured keratinocytes 
utilizing a liposome-based commercial kit (DOTAP, Boehringer Mann-
heim). The MMP-l construct, pCLCAT3 consisted of3.8 kb of collagenase 
promoter region linked to the chloramphenicol acetyl transferase (CAT) 
reporter gene [26]. The MMP-3 construct, 4+CAT, consisted of 1.3 kb of 
the stromelysin-l 5' -flanking DNA, also linked to the CAT reporter gene 
[22]. The promoter-CAT constructs were co-transfected with 2 J.,Lg of a 
RSV 1 (3-galactosidase construct (Promega) . IFN-)' was added to some 
cultures 1 h after transfection. Parallel cultures were transfected with a 
thymidine kinase (TK)-CA T construct, or a construct that contained three 
AP-l consensus sequences (5'-TGAGTCA-3') cloned in tandem in front of 
the TK promoter [27] , a construct referred here as [TREh TK-CAT (kindly 
provided by Dr. Steven Frisch, Washington University, St. Louis, MO). 
After 24 h of incubation, CAT activity was determined as described 
previously [28]. {3-galactosidase activity was determined in the same cell 
extracts [20] , and CAT activities were corrected for (3-galactosidase activity 
to normalize for small differences in the transfection efficiency. 
Gel Mobility Shift Assays Nuclear proteins were isolated from kerati-
nocytes incubated with or without IFN-)' (100 U/ml) for varying time 
periods up to 24 h [29). For the binding assay, a 20-bp double-stranded 
oligomer that contained the collagenase AP-l consensus sequence (see 
above), labeled radioactive by ae 2 p]ATP, was used as a probe for protein 
binding. The oligomer, containing approximately 5 X 104 cpm of radioac-
tivity, was incubated with 8 J.,Lg of the nuclear protein extract, and the 
DNA-protein complexes were fractionated on 4% polyacrylamide gel 
containing 0.4 X TBE under non-denaturing conditions, as described 
elsewhere [30]. The radioactive oligomer-protein complexes were visual-
ized by autoradiography by exposure of the gels to X-ray films with 
intensifying screens at -70°C. 
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RNA Stability Assay To determine the stability of MMP-l mRNA, 
parallel keratinocyte cultures were incubated without or with IFN-)' (100 
U/rnl) for 24 h, as indicated above. At this point (time 0) the cells were 
rinsed with phosphate-buffered saline, and fresh medium devoid of IFN-), 
but containing 60 mM DRB, an inducer of premature termination of 
transcription [31], was added. Total RNA was isolated from parallel cultures 
at different time points up to 48 h of incubation. The MMP-l mRNA levels 
were then determined by Northern hybridizations, followed by scanning 
densitometry, as described above. 
RESULTS 
IFN-y Enhances MMP-1 and MMP-3 mRNA Levels Expres-
sion of the MMP-l, MMP-3, and TIMP genes was first examined 
in cultured keratinocytes by assay of the corresponding mRNA 
steady-state levels by Northern analyses. In cultures incubated in 
serum-free medium containing 0.15 mM calcium, low, yet clearly 
detectable, levels of mRNAs for all three genes were detected (Fig 
1). Incubation of the cultured cells with IFN-y (100 U/ml) resulted 
in a significant, time-dependent increase in MMP-l and MMP-3 
mRNA levels (Fig 1). The maximum enhancement was noted at 12 
h of incubation in cases of both MMP-l and MMP-3 mRNAs (Fig 
1B). In contrast, the mRNA levels of TIMP were unaltered by 
IFN-y (Fig lB). Subsequent incubation of keratinocytes with 
varying concentrations (up to 1000 U/ml) of IFN-y for 24 h 
indicated a marked enhancement, up to approximately eightfold, of 
collagenase mRNA levels (Fig 2A), and maximum stimulation was 
reached already with lOU I ml of IFN -y (Fig 2B). Similar increases 
were noted in stromelysin mRNA levels, whereas the mRNA 
levels for TIMP were unaltered in these concentrations (Fig 2B). 
Thus, there is a coordinate upregulation of MMP-l and MMP-3 in 
cultured keratinocytes by IFN-y, and this enhancement is selective 
in that the TIMP mRNA levels are unaltered. 
To examine whether the enhancement of MMP-l and MMP-3 
gene expression, as detected at the mRNA level, is dependent of 
on-going protein synthesis, cell cultures were pre-incubated with 
cycloheximide (10 /Lg/ml) 1 h prior to addition of IFN-y. As 
indicated above, addition of IFN-y alone (100 U/ml) to keratino-
cyte cultures significantly increased the MMP-l and MMP-3 
mRNA levels in the absence of cycloheximide (Fig 3). Addition of 
cycloheximide to parallel cultures resulted in a marked reduction in 
the constitutive expression of MMP-l and MMP-3, respectively 
(Fig 3B). Furthermore, the addition of cycloheximide prevented 
the enhancement of the corresponding mRNA levels by IFN-y 
(Fig 3) . It should be noted that the glyceraldehyde-3-phosphate 
dehydrogenase levels in all cultures were essentially unaltered (Fig 
3A). Thus, the upregulation of MMP-l and MMP-3 gene expres-
sion, as determined at the mRNA level, is dependent on active 
protein synthesis. 
Enhanced MMP-l Expression by IFN-y at the Protein Level 
To demonstrate that the enhancement of MMP-l mRNA levels by 
IFN-y is accompanied by enhanced synthesis of the corresponding 
protein, Western analysis of the collagenase protein in medium of 
keratinocytes cultured in the presence of 0-100 U/ml ofIFN-y was 
performed. Western blot analyses revealed in control cultures a 
characteristic doublet consisting of collagenase precursor polypep-
tides of approximately 62 and 57 kDa in size (Fig 4). The intensity 
of these two bands was significantly enhanced in the presence ofl0 
or 100 U/ml ofIFN-y (Fig 4) . Thus, the elevated mRNA levels for 
MMP-l correlate with enhanced synthesis and secretion of immu-
nodetectable interstitial collagenase in keratinocyte cultures. 
Evidence for Post-Transcriptional Regulation To examine 
the possibility that the elevated mRNA levels for MMP-l and 
MMP-3 result from enhanced transcriptional activity of the corre-
sponding genes, promoter-reporter gene (CAT) constructs were 
used in transient transfections of cultured keratinocytes . One hour 
following the transfection with a MMP-l/CAT construct, IFN-y, 
in concentrations varying from 0 to 1000 U I ml was added to 
parallel duplicate cultures. Assay of CAT, as an indicator of the 
promoter activity, did not reveal any differences in the presence of 
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Figure 1. Time--dependent enhancement of collagenase (MMP- t ) and .strome.lysin (MMP-3) gene expression by interferon-y (lFN-y) . 
Epidennal keratinocytes in culture were: incubated with IFN-y for the time periods indicated. Total RNA (30 Jig) was &actiomued on 1% agarosc gel, 
tramferred to nitroceUulose filters, and h)'bridi.zcd successively widl MMP-I . MMP-3, TIMP. and gJyccraJdchyde-3-phosphate dehydrogenase (GAPDH) 
cONAl labeled radioactive by nick translation (A). Scanning densitometry of the autoradiogn.m demonstrates a marked enhancement ofMMP- t and MMP-3 
mRNA steady-state leveb. with the maximum enhancemenc noted lit 12 h ofincubacion after correction for GAPO H l ~veJs in the .same RNA preparations 
(8). In contralto IFN-y had no effect on the TIMP mRNA levels. 
varying concentrations of IFN-y (Fig 5). Similar results were 
obcained when MMP-3 promoter/CAT construCt was used for 
transient transfections (not shown) . Thw. these results suggest that 
the elevated mRNA levels for MMP-l and MMP-3 elicited by 
IFN-y may result from regulation at the post-transcriptional level. 
In transient traosfections of cultured keracinocytes. it was noted 
that the constitutive activity of MM.P-l promoter/CAT COIUtruct 
was relatively high in control cultures. Because previolls studies 
have suggested. that the AP-l binding sequence (TRE) may serve as 
an enhancer of coUagcnase or stromelysin promoter activity r 1 .2'1, 
the ability of AP-l to upregulate a heterologous promoter. thymi-
dine kinase (TK) . was examined in keratinocyce cultures. As shown 
in Fig 6A. TK-CAT alone gave a relative weak signal. whereas 
trausfections with the [TREh TK-CAT construct resulted in a 
markedly enhanced CAT activiry (Fig 6A) . However. addition of 
IFN-y to parallel culrures cransfected with the [TRE]J TK-CAT 
construct did Dot further enhance the CAT activity (Fig 6B). 
Furmernlorc. gel mobility shift assays indicated that control kcra-
tinocyte cultures contained significant TRE binding activity (AP-
I). but incubation of these cells with IFN-y (100 U/ml), up to 24 
h. did not appreciably alter the level of this activity, as detected by 
radio labeled oligomer/protein complex in gel mobility sh ifr assay 
(Fig 6C). These data further emphasize the possibility of post-
transcriptiona11evcl of regulation of MMP-l and MMP-3 expres-
sion by IFN-y in cultured keratinocytcs. 
Stabilizatio n of MMP- l mRNA by IFN-'Y To examine the 
effect of IFN-)' on MMP-l mRNA stability and turnover, kernti-
nocyte cui cures were first incubated with (100 U/ ml) or without 
IFN-), for 24 h. ORB, an inhibitor oftranscripcion. was then added. 
and the MMP-l and glyceraldehyde-3-phospharc dehydrogenase 
mRNA steady-state levels were deternuued by Northern hybrid-
izations at differem time points. In cui cures lllcubated without 
IFN-y the MMP-l mRNA steady-state levels. after correction for 
glyceraldehyde-3-phosphate dehydrogenase transcript levels, de-
dined in a time-dependent manner, and an approximately SOOIo 
reduction from the control levels (time 0 b) was noted between 8 
and 12 h of in cubation (Fig 7). In cultures incubated first with 
IFN-)" there was no reduction of MMP-1 mRNA leyels during dle 
firs t 8 It following addition of OllB (Fig 7). In subsequent time 
points. rhe MMP- l mRNA levels were reduced as compal'ed to the 
O-h culrures incubated with IFN-),. but the levels remained approx-
imately twofold higber at 24 h. as compared to cultures incubated 
without IFN-y (Fig 7). These dara provide evidence for illitiaJ 
stabili.zacion of MMP-I with IFN-),. 
D1SCU SION 
T he results of this sflIdy demonstrate uncoordinate regulation of 
two MMPs critical for degradation of the extracellular matrix of 
connective tissue. and their inhibitol', T IMP, by IFN-y in buman 
epidermal keratinocytes in culcure. Specifically. the MMP-l and 
MMP-3 mRNA levels were markedly, up to eightfold. increased by 
IFN-,,), in a cime- and dose-dcpendent mant1er. In contrast, IFN-")' in 
concentrations tested (0-1000 U/ml) did not alter the TlMP 
mRNA levels . The enbancement of MM1)-1 gene expression by 
IFN-y was also demonstrated at the protein level by Western 
immunoblot analysis of the secreted proteins. 
Previous studies have indicated that the expression of MMP-t 
and MMP-3 is sib'llificantly modulated in cultured fibroblast'S 12]. 
However. in a distinct contrast to the findings demonstrated in our 
study in keratinocytc cultures. IFN-y significantly decreased the 
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Figure 2. Dose-dependent e.nhance.ment of collagena.se (MMP-I) IURNA leve.1s by lFN-y. Cultured kc~tinocytcs were Illcubated with IFN-y in 
concttltl'atioml indicated fOT 21 b. Collagenase Il1R.NA and gIYc"l"rnldehyde-3-phosph:ne dehydrogenase neady-statc levels were dCfennined b)f Nonhern 
hybridi2::ations (A). III addition. slTOmdysin (MMP-J) and TlMP mRNA steady-state Icvell were deu~nnjued by re-hybridization of the same fliteu. as in Fig 
t (not shown). Scanning demiromctry indicated that significant increases in the collagenase aud ~tromclyrin mRNA levels were noted :already with 10 U/ ml 
of IFN-'Y. and further enhancement was noted in (he pre~ence of 1000 V/ml (8). 
expression of dIe corresponding genes in fibroblasc cultures. Similar 
down-regulation of coUagenase or scromcly in expression by IFN-y 
has also been previously reported in human articular chondrocytcs 
and alveolar macrophages It 1-13). Thus. me upregularion of 
coUagcn3sc and scromelysin gene expression by IFN-y. as deter-
mined at the mRNA sccady-.)utc levels. and in case of collagenase 
at the protein level as well. appears to be unique to human 
kcratinocyces among the cell types rested thus faT. 
The level of regulation of MMP-l and MMP-3 gene expression 
by IFN-y appeared to be pose-transcriptional. In support of chis 
conclusion were the observations that keracinocytcs uansiendy 
transfected with a coUagenase- or a 'ilTomelysin-prommer/CAT 
reporter gene construct failed to enhance the CAT activity in the 
presence of IFN-y. In contrast, mR.NA half-life studies utilizing 
ORB. :m inhibitor oftranscriprion, suggested that IFN-y proloitgs 
the half-life of collagenase mRNA leveh. mggcsting stabilization of 
the mRNA. Thus, enhanced st3bili[} of the collagenase mltNA 
could lead to elevated steady-stace Icvel~ of the mRNA transcript. 
and subsequent translation of the mR.NA to the corresponding 
proeein. as demonstrated by Weuem immunoblotcing analysi.s. 
leads to enbanced synthesis of procoUagenase. At dle same lime. 
scromelysin. which is required for maximal accivation of collage-
nase (3). is coordinately upregulaccd by I FN-y in the absence of 
noticeable changes in dle TIMP levels. Thus. thcse changes are 
expected to lead to an imbalance bcoH .. -cn the activity of these 
MMPs and their principal tiS(UC inhibitor. This situation potentially 
leads to enhanced degradation of the cxtraceUuJar matrix of 
connective tissue in ..-iruations involving close ceU-macrix i.nterac-
cions. such as wound-healing processes 19). 
[t is of interest to notc chat anolher cytokinc. cransfomung 
growth factor-{3 (TGF-f3), has been simi.larly shown to suppress the 
collagenase activity in fibroblasts, and tins inhibition involves two 
mechanisms [24). First, the synthesi.s of collagenase procein is 
inhibited by TGF-13 and. secondly, the synthesis of the inhibitor. 
TIMP. is upregulatcd. In contrasl. TGF-13 elevates collagenase 
activiry in kenltinocytcs. · These cdl type-specific dilfcrences sug~ 
gest differential signal~tran5dl1ction pachways. because tile cis-acting 
elements in the collagenase gClle ure expecred to be identical both 
in kcracinocytes and fibrobl:lsu. In chis contexc. it was of interest (0 
notc that the constirutive c).l'ression of coll agenase has been 
suggested to involve AP. I , and it.'" corrcsponding cis-acting binding 
clemen[. TRE 11.2). In this nudy. wc demonstrated in craruient 
rransfections thac keratinocytes upregulatc the expression of a 
heccrologous promoter, thymidine kinase, when linkcd to AP- I 
responsivc elcmcUl. TRE. However. IFN-'Y did not further en-
hance the acriviry of chis construct [TREhTK/CAT. These obser-
vations further atteSt to [he possibilicy that post-transcriptional 
regulation is responsible for IFN-y enhan ced expression of the 
collagenase in kcratinocytcs. 
An interesting observation noted in our study was chac the 
upregulacion ofMMP-1 and MMP-3 gene expression by IFN-y was 
sho\,ffl co be dependent on on-going procein synthesis. because 
addition of cyc10hcximjde to the cell cultures I h prior to dle 
addition of IFN-y abrogatcd the tFN-y effect. 11lls observation 
contrasts with previous demonstrations of cycloheximide-induced 
• Mlluviel A. Chen YQ. Dong \V. Tarnai K, Uino J: Cell-type specific 
induction of (-jll" ~Jld jun-B protD-Oncogenes by "GF-~ is responsible (or 
differential regulation of colJQgcnase gene exprcuion in fibrohlasts and 
keratinoc)'tCJ (abstr).) Illllt.lf Df!mtufn/ 102:528. 1994. 
388 TAMAI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
R B 
CHH + + 
-
Collagenase 
IFN-y + + 
-
Stromelysin 
CIt 
-m 
= m 
Collagenase -
= z 
= E 
m 5 
= 
--
.., 
fa 
6RPDH m 
= 
1 
CHH + + 
IFN-y + + 
Figure 3. The effect ofinterferon-jI on collagenase and stromelysin gene expression at the mRNA level is dependent on on-going protein 
synthesis. Cultured keratinocytes were incubated without (-) or with (+) 100 Vlml of IFN-y in the presence (+) or absence (-) of 10 J.Lg/ml of 
cycloheximide (CHX), which was added to the cultures 1 h prior to addition ofIFN-y. The steady-state levels of collagenase and stromelysin mRNA were 
determined, as described in Fig 1 (A), and the relative levels were determined by scanning densitometry after correction for the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA levels (B). 
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Figure 4. IFN-jI enhances collagenase (MMP-l) gene expression at 
the protein level. Cultured keratinocytes were incubated with IFN-y in 
concentrations indicated for 24 h, and the medium proteins were analyzed 
by Western immunoblotting utilizing a polyclonal anti-human collagenase 
antibody. Please note the characteristic doublet of bands of - 62 and 57 kDa 
(arrow). The positions of molecular weight markers (MW) are indicated on 
the right. 
I FN-y (U/ml) 0 10 102 103 
HC 
C 
% acetylation 68 58 59 55 
Figure 5. IFN-jI does not altt:r the collagenase-promoter/reporter 
gene construct expression in transient transfections of cultured 
human keratinocytes. The cells were transfected with the construct 
pCLCAT3 containing 3.8 kb of the promoter region of MMP-l linked to 
the CAT reporter gene. One hour following the transfection, IFN-y in 
concentrations indicated was added, and CAT activity was determined after 
24 h of incubation. The acetylated (AC) and non-acetylated (C) forms of 
C 4C]chloramphenicol were separated by thin-layer chromatography as 
described in the text, and CAT activity, expressed as percent acetylation of 
C 4C]chloramphenicol, is indicated. 
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Figure 6. IFN-y does not modulate AP-l-driven promoter activity or AP-l-binding activity in cultured human keratinocytes. A: Cultured 
keratinocytes were transfected in parallel with a thymidine kinase (TK)/CAT construct and a similar construct, [TRE] 3 TK/CAT, which contained in addition 
three AP-l-binding sequences (TRE) in tandem in front of the TK promoter. The expression ofTK-promoter/CAT construct was markedly enhanced by 
the presence of three upstream TRE sequences. B: Incubation of cells transfected with [TREh TK/CAT construct with IFN-y (1000 U/ml) did not change 
the level of expression. Note that A and B are two separate experiments and, therefore, the percent acetylation in control cultures transfected with 
[TREh TK/CAT incubated without IFN-y are different. C: Gel mobility shift assay with a radioactively labeled 20-bp oligomer containing the collagenase 
AP-l consensus binding sequence (TRE; see Materials and Methods), incubated with keratinocyte nuclear proteins, demonstrated a radioactive DNA/protein 
band (arrow). However, this binding activity did not change appreciably during incubation of the cells with IFN-y (1000 U/m!) up to 24 h . The C lane 
indicates reaction without nuclear proteins added to the binding reaction. 
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Figure 7. IFN-y stabilizes MMP-l mRNA and prolongs its half-life. 
Keratinocyte cultures were incubated without (~) or with (_ ) IFN-y (100 
U/ml) for 24 h. Cells were then rinsed with phosphate-buffered saline, and 
fresh medium containing 60 mM DRB was added (time 0 h). Total RNA 
was then isolated from parallel cultures at time points indicated, and the 
MMP-l mRNA levels were determined by Northern hybridizations. The 
values are expressed as percent of the mRNA levels in 0 hour cultures, after 
correction for glyceraldehyde-3-phosphate dehydrogenase mRNA levels. 
stromelysin mRNA levels in cultured human fibroblasts [22]. These 
observations further emphasize the differences noted in different 
cell types with respect to IFN-y effects on the regulation of these 
MMPs. Collectively, these results provide intriguing novel evi-
dence for the role of the cytokine network in regulating the 
extracellular matrix turnover in physiologic and pathologic situa-
tions. 
We thank Lin Lin, Tamara Alexander, and Debra Pawlicki Jor skillful technical 
assistance. Drs. Steven Frisch, Markku Kurkkinen, William Parks, and Howard 
We/gus kindly provided reagents Jor this study, and Drs. James Fox IV and James 
Moore, Jr. provided tissue Jor cell cultures . This work was supported in part by the 
United States Public Health Service, National Institutes oj Health grants R01-
AR41439 and T32-AR07561, and by the Dermatology Foundation. 
REFERENCES 
1. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective 
tissue remodeling. FASEB] 5:2145-2154, 1990 
2. Mauviel A: Cytokine regulation of metalloproteinase gene expression. ] Cell 
Bioclrern 53:288-295, 1993 
3. BrinckerhoffCE, Suzuki K, Mitchell TI, Oram F, Coon CI, Palmiter RD, Nagase 
H: Rabbit pro collagenase synthesized by a high-yield mammalian expression 
vector requires stromelysin (matrix metalloproteinase-3) for maximal activa-
tion. ] Bioi Chem 36:22262-22269, 1990 
4. Stricklin GP, Welgus HG: Human skin fibroblast collagenase inhibitor.] Bioi 
Citem 258 :12252-12258, 1983 
5. Stetler-Stevenson WG, Krutsch HC, Liotta LA: Tissue inhibitor of metaIlopro-
teinase (TIMP-2). A new member of the metaIloproteinase inhibitor family.] 
Bioi Chern 264:17374-17378,1989 
6. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm SM, He C: Human 72 
kD type IV collagenase forms a complex with a tissue inhibitor of metallopro-
teinase designated TIMP 2. Proc Natl Acad Sci USA 86:8207-8211, 1989 
390 TAMAI ET AL 
7. Brinckerhoff CE: Regulation of metalloproteinase gene expression: implications 
for osteoarthritis. Crit Rev Bl4kar Gene Exp 2:145-164, 1992 
8. Bauer EA, Vitto J, Eisen AZ: Collagenase in human cutaneous diseases: fidelity 
of expression in fibroblast cultures. In: Wagner BM, Fleischmajer R, Kaufinan 
N (eds.). Connective Tissue Diseases. William & Wilkins, Baltimore, MD, 1983, 
pp 129-136 
9. Mauviel A, Vitto J: The extracellular matrix in wound healing: role of the 
cytokine network. Wounds 5:137-152, 1993 
10. Sen GC, Lengyel P: The Interferon system: a bird's eye view of its biochemistry. 
] BioI Chern 267:5017-5020,1992 
11. Vnemori EN, Bair MJ, Bauer EA, Amento EP: Stromelysin expression regulates 
collagenase activation in human fibroblasts. ] Bioi Cltern 266:23477-23482, 
1991 
12. Andrews HJ, Bunning RAD, Plumpton TA, Clark 1M, Russell RGG, Cawston 
TE: Inhibition of interleukin-1-induced collagenase production in human 
articular chondrocytes in vitro by recombinant human interferon-gamma. 
Arthritis Rheum 33:1733-1738, 1990 
13. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG: Immune modulation of 
metalloproteinase production in human macrophages: selective pretransla-
tional suppression of interstitial collagenase and stromelysin biosynthesis by 
interferon-y.] Clin Invest 86:1204-1210,1990 
14. Petersen MJ, Woodley D, Stricklin GP, O'Keefe EJ: Production of procollag-
enase by cultured human keratinocytes.] Bioi Cllern 262:835-840, 1987 
15. Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ: Constitutive production of 
procollagenase and tissue inhibitor of metalloproteinases by human keratino-
cytes in culture.] Invest Dermatol92:156-159, 1989 
16. Saarialho-Kere U, Pentland AP, Birkedal-Hansen H, Parks WC, Wei gus HG: 
Distinct populations of basal keratinocytes express stromelysin-l and strome-
lysin-2 in chronic wounds.] Clin Invest 94:79-88, 1994 
17. Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ: Enhanced synthesis of 
collagenase by human keratinocytes cultured on type I or type IV collagen.] 
Invest Demtatol 94:341-346, 1990 
18. Sarret Y, Woodley DT, Goldberg GI, Kronberger A, Wynn KC: Constitutive 
synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by 
type I collagen and decreased by type IV collagen matrices . ] In.vest Dennatol 
99:836-841,1992 
19. Chomzynski P, Sacchi N : Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction . Alwl Biochel1l 162 : 
156-159,1987 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
20. Sam brook J, Fritsch EF, Maniatis T: Molecular Clon.ing: A Laboratory Manual, 2nd 
ed. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989 
21. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: 
Human fibroblast collagenase. Complete primary structure and homology to 
oncogene transformation-induced rat protein. ] Bioi Chern 261:6600-6605, 
1986 
22. Saus J, Quinones S, Otani Y, Nagase H, Harris ED, Jr, Kurkinen M: The 
complete primary structure of human matrix metalloproteinase-3. Identity 
with stromelysin.] Bioi Chern 263 :6742-6745, 1988 
23. Fort P, Marty L, Piechaczyk M, Sabrouty SEI, Dan D,Jeanteur P, BlanchardJM: 
Various rat adult tissues express only one major mRNA species from the 
glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acids Res 
13:1431-1442, 1985 
24. Mauviel A, Chen YQ, Dong W, Evans CH, VittoJ: Transcriptional interactions 
of transforming growth factor-{3 with pro-inflammatory cytokines. Cr~"e/lt Bioi 
3:822-831, 1993 
25. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks 
WC: Cell-matrix interactions modulate interstitial collagenase expression by 
human keratinocytes actively involved in wound healing.] Clill ltlllest 92: 
2858-2866, 1993 
26. Frisch SM, Reich R, Collier IE, Genrich LT, Martin G, Goldberg GI: Adenovirus 
E1A represses protease gene expression and inhibits metastasis of human tumor 
cells. Oncogetle 5:75-83, 1990 
27. Buttice G, Quinones S, Kurkinen M: The AP-1 site is required for basal 
expression but is not necessary for TPA-response of the human stromelysin 
gene. NlicI Acids R es 19:3723-3731,1991 
28 . Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express 
chloramphenicol acetyl transferase in mammalian cells . Mol Cell Bioi 2:1044-
1051, 1982 
29 . Andrews NC. Faller DV: A rapid micropreparation technique for extraction of 
DNA-binding proteins from limiting numbers of mammalian cells . Nucl Acids 
Res 19:2499,1991 
30 . Tamai K, Li K, Vitto J: Identification of a DNA-binding protein (keratinocyte 
transcriptional protein-1) recognizing a keratinocyte-specific regulatory ele-
ment in the 230-kDa bullous pemphigoid antigen gene.] Bioi Cltel1l 269:493-
502 , 1994 
31. Fraser NW. Sehgal PB, Darnell JE: DRB-induced premature termination oflate 
adenovirus transcription . Nature 272:590-593 , 1978 
